Early research (Phase 1)Not Yet RecruitingNCT07768592
What this trial is testing
Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2511 in Participants With Early Alzheimer's Disease (AD)
Who this might be right for
Alzheimers Disease
Eisai Inc. 32